 |
Novo Nordisk shifts US media business from WPP to OmnicomOmnicom Media Group has been awarded Novo Nordisk's US media account following a competitive review, ending the pharmaceutical giant's long-standing media relationship with WPP and marking another significant shift in the global agency landscape.  Source: www.unsplash.com The appointment covers media planning and buying in the US for Novo Nordisk, whose portfolio includes blockbuster diabetes and weight-loss brands Ozempic and Wegovy. The account is understood to be one of the year's most closely watched media pitches, given the rapid growth of the GLP-1 market and Novo Nordisk's sizeable advertising investment. The move represents another setback for WPP, which has been under pressure amid a series of account reviews and client changes globally. Novo Nordisk's decision follows a competitive process that saw Omnicom emerge as the successful bidder for the US business. |